Anuh Pharma - Going non-stop. Another 6.3% up today. Multi-year VCP Pattern BO happening. Volume build up is good. Just let it sustain above 261 levels until Weekly Close for rockets to Fly....Target 320, 445 (Still 2x to go from here). But fresh entries wait for BO confirmation on weekly. Remember - this is a Monthly Pattern. Even WEEKLY confirmation of BO is not good enough, but atleast we need to wait for this minimum
Disclaimer:
3+ Years Teaching Experience in Stock Market - Technical Analysis, Advanced Patterns, Emotional Management, News based Trading...
We are NOT SEBI Registered and Our focus is NOT providing Buy/Sell Recommendations/calls. Primary Objective is to provide detailed analysis of how to review a chart, explain multi-timeframe views purely for Educational Purposes.
We strongly suggest our followers to "Learn to Ride the Tide irrespective of its Side"
*** Important *** Consult your Financial Advisors before taking any positions
If you like our detailed analysis, please do rate us with your Likes, Boost and share your comments
-Team Stocks-n-Trends
Disclaimer:
3+ Years Teaching Experience in Stock Market - Technical Analysis, Advanced Patterns, Emotional Management, News based Trading...
We are NOT SEBI Registered and Our focus is NOT providing Buy/Sell Recommendations/calls. Primary Objective is to provide detailed analysis of how to review a chart, explain multi-timeframe views purely for Educational Purposes.
We strongly suggest our followers to "Learn to Ride the Tide irrespective of its Side"
*** Important *** Consult your Financial Advisors before taking any positions
If you like our detailed analysis, please do rate us with your Likes, Boost and share your comments
-Team Stocks-n-Trends
- Team Stocks-n-Trends
- Telegram: telegram.me/stocksntrends
- Telegram: telegram.me/stocksntrends
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
- Team Stocks-n-Trends
- Telegram: telegram.me/stocksntrends
- Telegram: telegram.me/stocksntrends
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。